First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer

To assess the accuracy of magnetic resonance imaging (MRI)/transrectal ultrasonography (TRUS) fusion to guide first‐round biopsies in the diagnosis of localised prostate cancer (PCa) in men with a prostate‐specific antigen (PSA) ≤10 ng/mL.

[1]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[2]  C Metcalfe,et al.  Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study , 2009, British Journal of Cancer.

[3]  Jocelyne Troccaz,et al.  Mapping of Transrectal Ultrasonographic Prostate Biopsies , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[4]  Nallasivam Palanisamy,et al.  Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA , 2011, Science Translational Medicine.

[5]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[6]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[7]  Jean-Jacques Patard,et al.  Value of Ultrasound-Guided Systematic Sextant Biopsies in Prostate Tumor Mapping , 1999, European Urology.

[8]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[9]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[10]  M. Emberton.  Has magnetic resonance-guided biopsy of the prostate become the standard of care? , 2013, European urology.

[11]  D. Bruzzese,et al.  Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml , 2013, PloS one.

[12]  J. Fütterer,et al.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.

[13]  A. Hoznek,et al.  Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria? , 2010, The Journal of urology.

[14]  B. Vainer,et al.  Is it possible to predict low‐volume and insignificant prostate cancer by core needle biopsies? , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  L. Salomon,et al.  Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial. , 2013, The Journal of urology.

[16]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[17]  P. Walsh,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The Journal of urology.

[18]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[19]  Jocelyne Troccaz,et al.  Prostate biopsy tracking with deformation estimation , 2011, Medical Image Anal..

[20]  Xavier Leroy,et al.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.

[21]  P. Grenier,et al.  Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. , 2013, Urologic oncology.

[22]  P. Carroll,et al.  Transrectal ultrasonography‐guided biopsy does not reliably identify dominant cancer location in men with low‐risk prostate cancer , 2012, BJU international.

[23]  U. Capitanio,et al.  The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy , 2011, BJU international.

[24]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[25]  Thomas Hambrock,et al.  Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. , 2013, European urology.

[26]  Naira Muradyan,et al.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. , 2013, The Journal of urology.

[27]  K. Fareed,et al.  Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml. , 2014, European urology.

[28]  Bernadette Coles,et al.  The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression? , 2008, Cancer.

[29]  Maarten de Rooij,et al.  Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. , 2014, European urology.

[30]  Baris Turkbey,et al.  Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. , 2012, The Journal of urology.

[31]  Gaelle Fiard,et al.  Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. , 2013, Urology.

[32]  P. Choyke,et al.  Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. , 2013, The Journal of urology.